2011-002780-16: A study of efficacy and safety of the glucose lowering drug Exenatide on patients with suspected acute stroke and hyperglycemia |
|
|
| Ongoing | 2 | 100 | Europe | Byetta, Novorapid, A10AB05, Solution for injection in pre-filled pen, Byetta, Novorapid | Karolinska Institutet, Karolinska institutet Södersjukhuset | Patients with hyperglycemia and symptoms of acute stroke will be randomized to either subcutaneous injection with 10ug of Byetta or standard care., Patients with hyperglycemia and symptoms of acute stroke will be randomized to either subcutaneous injection with 10ug of the glucose lowering drug Byetta or standard care against hyperglycemia., Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2008-005263-34: The effect of insulin therapy on beta-cell survival in patients with Maturity Onset Diabetes of the Young ( MODY) 3. A 2 year, single-centre, open-label, randomised, parallel-group trial comparing insulin therapy to conventional oral sulphonyurea on beta-cell survival. |
|
|
| Ongoing | 2 | 40 | Europe | Diamicron, NovoRapid, Levemir, Diamicron, NovoRapid, Levemir, Diamicron, NovoRapid, Levemir | The Mater Foundation/HRB Grant | The effect of insulin therapy on beta-cell survival in patients with Maturity Onset Diabetes of the Young ( MODY ) 3. | | | | |
